Metabolic Disorders :
Explore Genetic Insights
Summary
Diseases Found | 46 |
High Risk | 1 |
Medium Risk | 43 |
Low Risk | 2 |
Mutated Genes Found | 21 |
Contents
- Autoimmune Disorders Page 1
- Brain Health (Neurological Disorders) Page 2
- Cancers (Neoplastic Diseases) Page 3
- Dermatological Diseases Page 4
- Endocrine Disorders Page 5
- Gastrointestinal Disorders Page 6
- Genitourinary Disorders Page 7
- Heart Health (Cardiovascular Diseases) Page 8
- Hematological Disorders Page 9
- Metabolic Disorders Page 10
- Musculoskeletal Diseases Page 11
- Obstetric and Gynecological Disorders Page 12
- Ophthalmological Diseases Page 13
- Appendix
Metabolic Disorders :
The following diseases are associated with Metabolic Disorders ::
Disease | Predisposition |
---|---|
Carbohydrate Metabolism, Inborn Errors | Medium |
Lipid Metabolism Disorders | Medium |
Lipidoses | Medium |
Obesity | Medium |
Diabetes Mellitus, Type 1 | Medium |
Lipid Metabolism, Inborn Errors | Medium |
Carbohydrate Metabolism, Inborn Errors
Type of carbohydrate metabolic disorder: Several, including but not limited to: 1. Glycogen storage diseases (GSD) 2. Galactosemia 3. Fructose intolerance Type of genetic transmission: Mostly autosomal recessive.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
MROH2B | Duplication | A/C | Medium |
ACAD9 | Deletion | G/A | Medium |
SLC12A7 | Duplication | C/A | High |
GSTM4 | Deletion | C/T | Medium |
ACTN2 | Deletion | C/C | Medium |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
MROH2B | 17% |
ACAD9 | 23% |
SLC12A7 | 3% |
GSTM4 | 12% |
ACTN2 | 23% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-1430728 | Dopaminergic Signaling | Controls cell differentiation |
REACT:R-HSA-611105 | GABAergic Signaling | Critical for embryonic development |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
MROH2B | Hypertension | Cellular apoptosis |
ACAD9 | Hypertension | Chronic infection |
SLC12A7 | Hypertension | Genetic predisposition |
GSTM4 | Cancer | Hormonal imbalance |
ACTN2 | Stroke | Chronic infection |
Recommendations for Medium Risk for Carbohydrate Metabolic Disorder
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for carbohydrate metabolism, inborn errors.
Lipid Metabolism Disorders
Lipid metabolism disorders can be of various types, including: 1. Hyperlipidemia (e.g., familial hypercholesterolemia) 2. Lipid storage diseases (e.g., Gaucher's disease, Niemann-Pick disease) 3. Disorders of fatty acid oxidation (e.g., Medium-chain acyl-CoA dehydrogenase deficiency, MCAD) Type of genetic transmission: - Many lipid metabolism disorders are inherited in an autosomal recessive manner, where both copies of the gene must be mutated for the disorder to be expressed. - Some, like familial hypercholesterolemia, can be inherited in an autosomal dominant manner, where only one copy of the mutated gene is sufficient to cause the disorder.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
ZNF518B | Frameshift | T/G | High |
FOXD4 | Frameshift | G/A | High |
GSTM4 | Substitution | C/A | Medium |
SDHA | Inversion | G/A | Medium |
TMEM45A | Duplication | A/G | Medium |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
ZNF518B | 14% |
FOXD4 | 16% |
GSTM4 | 14% |
SDHA | 15% |
TMEM45A | 3% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-1430728 | NF-kappa B Signaling Pathway | Influences inflammatory response |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
ZNF518B | Asthma | Neurodegeneration |
FOXD4 | Stroke | Neurodegeneration |
GSTM4 | Osteoporosis | Oxidative stress |
SDHA | Coronary Artery Disease | Metabolic dysregulation |
TMEM45A | Diabetes | Chronic infection |
Recommendations for Medium Risk for Lipid Metabolism Disorder
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for lipid metabolism disorders.
Lipidoses
Mucolipidosis is classified into several types (I, II, III, and IV) based on the specific enzyme deficiency and clinical presentation. The types of genetic transmission for mucolipidosis are as follows: - Mucolipidosis I: Autosomal recessive - Mucolipidosis II (I-cell disease) and III (pseudo-Hurler polydystrophy): Autosomal recessive - Mucolipidosis IV: Autosomal recessive
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
FAM110C | Frameshift | C/A | Medium |
SDHA | Duplication | G/G | Medium |
MROH2B | Insertion | G/C | High |
SLC12A7 | Frameshift | G/G | High |
ZNF518B | Substitution | C/G | High |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
FAM110C | 16% |
SDHA | 23% |
MROH2B | 2% |
SLC12A7 | 18% |
ZNF518B | 22% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-1430728 | TGF-beta Signaling Pathway | Regulates neurotransmitter release |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
FAM110C | Coronary Artery Disease | Hormonal imbalance |
SDHA | Parkinson's Disease | Metabolic dysregulation |
MROH2B | Asthma | Oxidative stress |
SLC12A7 | Coronary Artery Disease | Mitochondrial impairment |
ZNF518B | Coronary Artery Disease | Mitochondrial impairment |
Recommendations for Medium Risk for Mucolipidosis
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for lipidoses.
Obesity
Obesity can have a multifactorial genetic transmission. It is influenced by a combination of multiple genes and environmental factors, rather than being transmitted through a simple Mendelian inheritance pattern. Specific genetic variations, such as those in the FTO gene, can increase susceptibility to obesity, but lifestyle and environmental factors play significant roles as well.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
ZNF518B | Frameshift | A/C | High |
ZFYVE9 | Insertion | C/A | High |
GRM6 | Inversion | G/T | Medium |
GTPBP8 | Deletion | A/C | High |
FOXD4 | Frameshift | C/C | High |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
ZNF518B | 1% |
ZFYVE9 | 2% |
GRM6 | 7% |
GTPBP8 | 23% |
FOXD4 | 18% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-114608 | Cholinergic Pathway | Regulates neurotransmitter release |
REACT:R-HSA-76005 | NF-kappa B Signaling Pathway | Regulates neurotransmitter release |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
ZNF518B | Asthma | Chronic infection |
ZFYVE9 | Depression | Oxidative stress |
GRM6 | Hypertension | Neurodegeneration |
GTPBP8 | Diabetes | Neurodegeneration |
FOXD4 | Hypertension | Chronic infection |
Recommendations for Medium Risk for Obesity
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for Obesity.
Diabetes Mellitus, Type 1
Diabetes mellitus includes several types, primarily Type 1 diabetes and Type 2 diabetes. - Type 1 diabetes: This type has an autoimmune component and is influenced by multiple genes. It is typically inherited in a polygenic manner, meaning several genes may contribute to the risk. - Type 2 diabetes: This type is more strongly associated with lifestyle factors but also has a genetic component. It is also inherited in a polygenic manner, with multiple genes contributing to the overall risk. Gestational diabetes and other forms can also have genetic predispositions but are influenced by additional specific factors.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
GRM6 | Deletion | A/G | High |
PHACTR2 | Inversion | T/G | Medium |
ACTN2 | Duplication | A/C | High |
PUM3 | Deletion | T/G | High |
ZDHHC11 | Substitution | C/A | High |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
GRM6 | 16% |
PHACTR2 | 16% |
ACTN2 | 25% |
PUM3 | 14% |
ZDHHC11 | 21% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-114608 | Hedgehog Signaling Pathway | Plays a role in synaptic plasticity |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
GRM6 | Cancer | Cellular apoptosis |
PHACTR2 | Diabetes | Oxidative stress |
ACTN2 | Depression | Inflammation |
PUM3 | Cancer | Oxidative stress |
ZDHHC11 | Diabetes | Chronic infection |
Recommendations for Medium Risk for Diabetes Mellitus
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for Diabetes Mellitus, Type 1.
Lipid Metabolism, Inborn Errors
Lipid metabolism disorders can be of various types, including: 1. Hyperlipidemia (e.g., familial hypercholesterolemia) 2. Lipid storage diseases (e.g., Gaucher's disease, Niemann-Pick disease) 3. Disorders of fatty acid oxidation (e.g., Medium-chain acyl-CoA dehydrogenase deficiency, MCAD) Type of genetic transmission: - Many lipid metabolism disorders are inherited in an autosomal recessive manner, where both copies of the gene must be mutated for the disorder to be expressed. - Some, like familial hypercholesterolemia, can be inherited in an autosomal dominant manner, where only one copy of the mutated gene is sufficient to cause the disorder.
Associated Genes
Gene | Mutation Type | Allele | Confidence |
---|---|---|---|
MROH2B | Frameshift | A/G | Medium |
ACTN2 | Duplication | A/A | High |
ACAD9 | Frameshift | C/T | Medium |
ZDHHC11 | Duplication | G/T | High |
ACAD9-DT | Deletion | T/T | High |
Population Frequency By Gene
Population frequency indicates how common a specific genetic variant is within a group of people, expressed as a percentage. For example, if a gene variant has a frequency of 20%, it means about 20 out of 100 individuals carry that variant. This information helps researchers understand the potential impact of genetic variants on health and traits within different populations.
Gene | Frequency |
---|---|
MROH2B | 18% |
ACTN2 | 24% |
ACAD9 | 10% |
ZDHHC11 | 18% |
ACAD9-DT | 22% |
Associated Pathways
A pathway refers to a series of biochemical reactions and interactions that occur within cells, allowing for communication between genes, proteins, and metabolites. These pathways are crucial for various physiological functions, including neurotransmission, hormone signaling, and metabolic processes, and can influence behaviors and health outcomes when disrupted by genetic mutations.
Pathway | Type | Effects |
---|---|---|
REACT:R-HSA-1430728 | Notch Signaling Pathway | Involved in cell growth and survival |
REACT:R-HSA-611105 | MAPK Signaling Pathway | Impacts cellular stress response |
REACT:R-HSA-114608 | GABAergic Signaling | Modulates metabolism and energy use |
REACT:R-HSA-76005 | Cholinergic Pathway | Plays a role in synaptic plasticity |
Possible Comobordities
Comorbidities are additional health conditions that often occur alongside a primary condition. For example, someone with ADHD may also have other related issues, such as anxiety or learning difficulties. These conditions are linked because they may share similar causes, such as genetics or brain chemistry, making it more likely for a person to experience both at the same time.
Gene | Comorbidities | Associated Mechanism |
---|---|---|
MROH2B | Coronary Artery Disease | Chronic infection |
ACTN2 | Diabetes | Neurodegeneration |
ACAD9 | Stroke | Genetic predisposition |
ZDHHC11 | Hypertension | Hormonal imbalance |
ACAD9-DT | Asthma | Immune system dysfunction |
Recommendations for Medium Risk for Lipid Metabolism Disorder
- Consultation: Schedule a follow-up consultation with a primary care provider or genetic counselor.
- Monitoring: Regularly monitor your health for early signs of the condition associated with your predisposition.
- Lifestyle Adjustments: Implement moderate lifestyle changes to mitigate risk.
- Personalized Lifestyle Plan:
- Maintain a balanced diet rich in whole foods, lean protein, and healthy fats.
- Engage in regular physical activity, such as walking, swimming, or light strength training.
- Incorporate stress management techniques like deep breathing exercises or light yoga.
- Limit alcohol consumption and reduce exposure to pollutants.
For additional guidance on managing your predisposition: See treatment options for Lipid Metabolism, Inborn Errors.
Appendix
Mutated Genes Found
Gene | Associated Diseases | Chromosome Position |
---|---|---|
SLC12A7 |
|
Chr15:80396464 |
ANK2 |
|
Chr5:94485476 |
ZFYVE9 |
|
Chr3:74971654 |
FOXD4 |
|
Chr11:60498505 |
ACAD9-DT |
|
Chr4:79713221 |
PUM3 |
|
Chr14:23898750 |
MRPL36 |
|
Chr9:35566705 |
GSTM4 |
|
Chr4:34143173 |
TMEM45A |
|
Chr5:63416169 |
ZDHHC11 |
|
Chr1:60291202 |
ZNF518B |
|
ChrX:43048996 |
GTPBP8 |
|
Chr4:67790340 |
PHACTR2 |
|
Chr11:30756143 |
MROH2B |
|
Chr15:61771817 |
GRM6 |
|
Chr20:15606114 |
NQO2 |
|
Chr10:91312362 |
SDHA |
|
Chr9:95567056 |
ACAD9 |
|
Chr11:98058058 |
LRPPRC |
|
ChrY:71292215 |
ACTN2 |
|
Chr5:78531986 |
FAM110C |
|
Chr20:97823299 |
Diseases Found
Disease | Category | Predisposition |
---|---|---|
immune system diseases | Autoimmune Disorders : | Medium |
Autoimmune Diseases | Autoimmune Disorders : | Medium |
Connective Tissue Diseases | Autoimmune Disorders : | Low |
demyelinating autoimmune diseases, cns | Autoimmune Disorders : | Low |
Alzheimer Disease | Brain Health (Neurological Disorders) | High |
Nervous System Diseases | Brain Health (Neurological Disorders) | Medium |
Neurodegenerative Diseases | Brain Health (Neurological Disorders) | Medium |
Cerebrovascular Disorders | Brain Health (Neurological Disorders) | Medium |
central nervous system diseases | Brain Health (Neurological Disorders) | Medium |
brain diseases, metabolic | Brain Health (Neurological Disorders) | Medium |
neuromuscular diseases | Brain Health (Neurological Disorders) | Medium |
lysosomal storage diseases, nervous system | Brain Health (Neurological Disorders) | Medium |
neurologic manifestations | Brain Health (Neurological Disorders) | Medium |
cranial nerve diseases | Brain Health (Neurological Disorders) | Medium |
Spinal Cord Ischemia | Brain Health (Neurological Disorders) | Medium |
genital neoplasms, male | Cancers (Neoplastic Diseases) | Medium |
Prostatic Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Breast Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Gastrointestinal Neoplasms | Cancers (Neoplastic Diseases) | Medium |
Digestive System Neoplasms | Cancers (Neoplastic Diseases) | Medium |
skin and connective tissue diseases | Dermatological Diseases : | Medium |
Endocrine System Diseases | Endocrine Disorders : | Medium |
digestive system diseases | Gastrointestinal Disorders : | Medium |
Gastrointestinal Diseases | Gastrointestinal Disorders : | Medium |
Intestinal Diseases | Gastrointestinal Disorders : | Medium |
Male Urogenital Diseases | Genitourinary Disorders : | Medium |
Cardiovascular Abnormalities | Heart Health (Cardiovascular Diseases) | Medium |
Cardiomyopathy, Hypertrophic | Heart Health (Cardiovascular Diseases) | Medium |
Vascular Diseases | Heart Health (Cardiovascular Diseases) | Medium |
Hypertension | Heart Health (Cardiovascular Diseases) | Medium |
Coronary Artery Disease | Heart Health (Cardiovascular Diseases) | Medium |
hemic and lymphatic diseases | Hematological Disorders : | Medium |
Hematologic Diseases | Hematological Disorders : | Medium |
Blood Coagulation Disorders | Hematological Disorders : | Medium |
Hemorrhagic Disorders | Hematological Disorders : | Medium |
Thrombophilia | Hematological Disorders : | Medium |
carbohydrate metabolism, inborn errors | Metabolic Disorders : | Medium |
lipid metabolism disorders | Metabolic Disorders : | Medium |
lipidoses | Metabolic Disorders : | Medium |
Obesity | Metabolic Disorders : | Medium |
Diabetes Mellitus, Type 1 | Metabolic Disorders : | Medium |
Lipid Metabolism, Inborn Errors | Metabolic Disorders : | Medium |
musculoskeletal diseases | Musculoskeletal Diseases : | Medium |
Muscular Diseases | Musculoskeletal Diseases : | Medium |
female urogenital diseases and pregnancy complications | Obstetric and Gynecological Disorders : | Medium |
female urogenital diseases and pregnancy complications | Ophthalmological Diseases : | Medium |